← Leaderboards
Richard Charles Shelton
Vanderbilt University
$9,245,563
Attributed
$14,756,247
Total exposure
9
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,756,247 · 9
By mechanism
R01$12,442,594 · 6
RF1$1,479,918 · 1
K24$425,360 · 1
R21$408,375 · 1
Top collaborators
- Yogesh Dwivedi17 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Richard M O'Brien$22,760,592
- Thomas Andl$1,721,911
- Maureen K Hahn$1,161,503
- David W. Piston$26,670,947
- Kirsty A Clark$1,885,071
Others in their field
Top investigators on “Major Depressive Disorder”
- Jill M Goldstein · Massachusetts General Hospital$31,618,561
- Myrna M Weissman · New York State Psychiatric Institute$26,406,289
- Joseph J Mann · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc$25,282,435
- David Maklan · Westat, Inc.$24,725,138
- Patrick F Sullivan · Univ Of North Carolina Chapel Hill$24,216,675
- Diego A. Pizzagalli · Harvard University$23,449,370
Research focus
Major Depressive DisorderResponseGene ExpressionBrainMental DepressionAffectPlasmaMicrornasRecording Of Previous EventsHostilitySuicideMolecularSuicidalFeeling SuicidalPatternSuicidal PatientAggressive BehaviorExosomePathway InteractionsImpulsivitySuicide AttemptAutopsyClinical ResearchAntidepressive Agents
Grant awards (32)
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents$1,479,918
RF1 · FY2025 · MH
MicroRNA Correlates of Childhood Maltreatment and Suicidality$702,491
R01 · FY2025 · MH
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents$739,959
R01 · FY2024 · MH
MicroRNA Correlates of Childhood Maltreatment and Suicidality$702,491
R01 · FY2024 · MH
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents$739,959
R01 · FY2023 · MH
MicroRNA Correlates of Childhood Maltreatment and Suicidality$632,241
R01 · FY2023 · MH
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents$733,872
R01 · FY2022 · MH
MicroRNA Correlates of Childhood Maltreatment and Suicidality$667,367
R01 · FY2022 · MH
MicroRNA Correlates of Childhood Maltreatment and Suicidality$702,491
R01 · FY2021 · MH
Plasma Exosomal MicroRNAs as Promising Novel Biomarkers for Suicidality and Treatment Outcome$698,326
R01 · FY2019 · MH
Plasma Exosomal MicroRNAs as Promising Novel Biomarkers for Suicidality and Treatment Outcome$701,415
R01 · FY2018 · MH
MicroRNA Mediators of Early Life Stress Vulnerability and Resilience$185,625
R21 · FY2018 · MH · contact PI
Plasma Exosomal MicroRNAs as Promising Novel Biomarkers for Suicidality and Treatment Outcome$700,978
R01 · FY2017 · MH
MicroRNA Mediators of Early Life Stress Vulnerability and Resilience$222,750
R21 · FY2017 · MH · contact PI
Plasma Exosomal MicroRNAs as Promising Novel Biomarkers for Suicidality and Treatment Outcome$639,458
R01 · FY2016 · MH
Plasma Exosomal MicroRNAs as Promising Novel Biomarkers for Suicidality and Treatment Outcome$61,520
R01 · FY2016 · MH
Plasma Exosomal MicroRNAs as Promising Novel Biomarkers for Suicidality and Treatment Outcome$710,508
R01 · FY2015 · MH
2/2-Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression (TRD)$311,586
R01 · FY2012 · MH · contact PI
2/2-Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression (TRD)$342,379
R01 · FY2011 · MH · contact PI
2/2-Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression (TRD)$345,838
R01 · FY2010 · MH · contact PI
2/2-Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression (TRD)$345,838
R01 · FY2009 · MH · contact PI
2/2-Ziprasidone Augmentation of SSRIs for Treatment-Resistant Depression (TRD)$310,838
R01 · FY2008 · MH · contact PI
Signal Transduction in Depression$301,824
R01 · FY2008 · MH · contact PI
Signal Transduction in Depression$301,415
R01 · FY2007 · MH · contact PI
Signal Transduction in Depression$302,829
R01 · FY2006 · MH · contact PI
MOLECULAR NEUROBIOLOGY OF DEPRESSION$106,340
K24 · FY2003 · MH
DEPRESSION--PSYCHOPATHOLOGY BEYOND THE RECEPTORS$254,216
R01 · FY2002 · MH
MOLECULAR NEUROBIOLOGY OF DEPRESSION$106,340
K24 · FY2002 · MH
DEPRESSION--PSYCHOPATHOLOGY BEYOND THE RECEPTORS$247,159
R01 · FY2001 · MH
MOLECULAR NEUROBIOLOGY OF DEPRESSION$106,340
K24 · FY2001 · MH
DEPRESSION--PSYCHOPATHOLOGY BEYOND THE RECEPTORS$245,596
R01 · FY2000 · MH
MOLECULAR NEUROBIOLOGY OF DEPRESSION$106,340
K24 · FY2000 · MH